Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
abcellera
antibodies
azacitidine
beta-thalassemia
boston
boston blog main
boston top stories
coronavirus
covid-19
dacogen
deals
decitabine
dna
drug discovery
eli lilly
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
insulated genomic domains
kaleido biosciences
mahesh karande
national
new york blog main
new york top stories
omega therapeutics
panobinostat
partnership
pharma
richard young
robert gould
rudolf jaenisch
san francisco blog main
san francisco top stories
sickle cell disease
What
based
3
×
biotech
3
×
medicines
3
×
research
abcellera
abcellera’s
aims
alderley
amadeus
antibodies
antibody
approach
biologics
called
capital
catapult
centre
cheshire
chief
commercial
coronavirus
debuts
developing
discovery
drugs
enter
epigenetic
epigenetics
field
flagship’s
hirsch
identified
innovation
investor
joins
leads
long
medicine
morning
neutralizing
Language
unset
Current search:
biotech
×
medicines
×
based
×
@tech.eu
1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
